{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,2]],"date-time":"2022-04-02T13:22:00Z","timestamp":1648905720525},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2015,6,5]],"date-time":"2015-06-05T00:00:00Z","timestamp":1433462400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science","award":["25241015"],"award-info":[{"award-number":["25241015"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Ophthalmol"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1007\/s10792-015-0089-z","type":"journal-article","created":{"date-parts":[[2015,6,4]],"date-time":"2015-06-04T11:29:31Z","timestamp":1433417371000},"page":"159-169","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Effect of aflibercept in patients with age-related macular degeneration"],"prefix":"10.1007","volume":"36","author":[{"given":"Hiroko","family":"Okuma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuya","family":"Mimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mari","family":"Goto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuko","family":"Kamei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maiko","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aki","family":"Kondo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masao","family":"Matsubara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,6,5]]},"reference":[{"issue":"8","key":"89_CR1","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1016\/S0161-6420(00)00175-5","volume":"107","author":"MR VanNewkirk","year":"2000","unstructured":"VanNewkirk MR, Nanjan MB, Wang JJ, Mitchell P, Taylor HR, McCarty CA (2000) The prevalence of age-related maculopathy: the visual impairment project. Ophthalmology 107(8):1593\u20131600","journal-title":"Ophthalmology"},{"issue":"2","key":"89_CR2","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1001\/archopht.118.2.264","volume":"118","author":"LM Weih","year":"2000","unstructured":"Weih LM, VanNewkirk MR, McCarty CA, Taylor HR (2000) Age-specific causes of bilateral visual impairment. Arch Ophthalmol 118(2):264\u2013269","journal-title":"Arch Ophthalmol"},{"issue":"1","key":"89_CR3","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ajo.2007.03.047","volume":"144","author":"I Maruko","year":"2007","unstructured":"Maruko I, Iida T, Saito M, Nagayama D, Saito K (2007) Clinical characteristics of exudative age-related macular degeneration in Japanese patients. Am J Ophthalmol 144(1):15\u201322","journal-title":"Am J Ophthalmol"},{"issue":"10","key":"89_CR4","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1007\/s00417-005-1139-4","volume":"243","author":"RM Silva","year":"2005","unstructured":"Silva RM, Figueira J, Cachulo ML, Duarte L, Faria de Abreu JR, Cunha-Vaz JG (2005) Polypoidal choroidal vasculopathy and photodynamic therapy with verteporfin. Graefes Arch Clin Exp Ophthalmol 243(10):973\u2013979","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"1","key":"89_CR5","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ajo.2007.03.014","volume":"144","author":"A Otani","year":"2007","unstructured":"Otani A, Sasahara M, Yodoi Y, Aikawa H, Tamura H, Tsujikawa A, Yoshimura N (2007) Indocyanine green angiography: guided photodynamic therapy for polypoidal choroidal vasculopathy. Am J Ophthalmol 144(1):7\u201314","journal-title":"Am J Ophthalmol"},{"issue":"3","key":"89_CR6","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1136\/bjo.2008.150029","volume":"94","author":"GT Kokame","year":"2010","unstructured":"Kokame GT, Yeung L, Lai JC (2010) Continuous anti-VEGF treatment with ranibizumab for polypoidal choroidal vasculopathy: 6-month results. Br J Ophthalmol 94(3):297\u2013301","journal-title":"Br J Ophthalmol"},{"issue":"12","key":"89_CR7","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1016\/j.ophtha.2012.09.006","volume":"119","author":"JS Heier","year":"2012","unstructured":"Heier JS, Brown DM, Chong V, Korobelnik JF, Kaiser PK, Nguyen QD, Kirchhof B, Ho A, Ogura Y, Yancopoulos GD, Stahl N, Vitti R, Berliner AJ, Soo Y, Anderesi M, Groetzbach G, Sommerauer B, Sandbrink R, Simader C, Schmidt-Erfurth U, VIEW 1 and VIEW 2 Study Groups (2012) Intravitreal aflibercept (VEGF trap-eye) in wet age-related macular degeneration. Ophthalmology 119(12):2537\u20132548","journal-title":"Ophthalmology"},{"issue":"1","key":"89_CR8","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.ophtha.2013.08.011","volume":"121","author":"U Schmidt-Erfurth","year":"2014","unstructured":"Schmidt-Erfurth U, Kaiser PK, Korobelnik JF, Brown DM, Chong V, Nguyen QD, Ho AC, Ogura Y, Simader C, Jaffe GJ, Slakter JS, Yancopoulos GD, Stahl N, Vitti R, Berliner AJ, Soo Y, Anderesi M, Sowade O, Zeitz O, Norenberg C, Sandbrink R, Heier JS (2014) Intravitreal aflibercept injection for neovascular age-related macular degeneration: ninety-six-week results of the VIEW studies. Ophthalmology 121(1):193\u2013201","journal-title":"Ophthalmology"},{"issue":"1","key":"89_CR9","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1136\/bjophthalmol-2014-305076","volume":"99","author":"Y Ogura","year":"2015","unstructured":"Ogura Y, Terasaki H, Gomi F, Yuzawa M, Iida T, Honda M, Nishijo K, Sowade O, Komori T, Schmidt-Erfurth U, Simader C, Chong V, VIEW 2 Investigators (2015) Efficacy and safety of intravitreal aflibercept injection in wet age-related macular degeneration: outcomes in the Japanese subgroup of the VIEW 2 study. Br J Ophthalmol 99(1):92\u201397","journal-title":"Br J Ophthalmol"},{"issue":"2","key":"89_CR10","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s40123-013-0015-2","volume":"2","author":"G Trichonas","year":"2013","unstructured":"Trichonas G, Kaiser PK (2013) Aflibercept for the treatment of age-related macular degeneration. Ophthalmol Ther 2(2):89\u201398","journal-title":"Ophthalmol Ther"},{"issue":"3","key":"89_CR11","first-page":"434","volume":"32","author":"MW Stewart","year":"2012","unstructured":"Stewart MW, Rosenfeld PJ, Penha FM, Wang F, Yehoshua Z, Bueno-Lopez E, Lopez PF (2012) Pharmacokinetic rationale for dosing every 2 versus 4\u00a0weeks with intravitreal ranibizumab, bevacizumab, and aflibercept (vascular endothelial growth factor Trap-eye). Retina 32(3):434\u2013457","journal-title":"Retina"},{"issue":"2","key":"89_CR12","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1076\/opep.9.2.83.1523","volume":"9","author":"B Thylefors","year":"2002","unstructured":"Thylefors B, Chylack LT Jr, Konyama K, Sasaki K, Sperduto R, Taylor HR, West S, WHO Cataract Grading Group (2002) A simplified cataract grading system. Ophthalmic Epidemiol 9(2):83\u201395","journal-title":"Ophthalmic Epidemiol"},{"key":"89_CR13","doi-asserted-by":"crossref","first-page":"273754","DOI":"10.1155\/2014\/273754","volume":"2014","author":"M Gharbiya","year":"2014","unstructured":"Gharbiya M, Iannetti L, Parisi F, De Vico U, Mungo ML, Marenco M (2014) Visual and anatomical outcomes of intravitreal aflibercept for treatment-resistant neovascular age-related macular degeneration. Biomed Res Int 2014:273754","journal-title":"Biomed Res Int"},{"issue":"2","key":"89_CR14","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1001\/2013.jamaophthalmol.228","volume":"131","author":"H Noma","year":"2013","unstructured":"Noma H, Mimura T, Eguchi S (2013) Association of inflammatory factors with macular edema in branch retinal vein occlusion. JAMA Ophthalmol 131(2):160\u2013165","journal-title":"JAMA Ophthalmol"},{"issue":"3","key":"89_CR15","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s10792-012-9676-4","volume":"33","author":"H Noma","year":"2013","unstructured":"Noma H, Shimada K, Mimura T (2013) Visual function after pars plana vitrectomy in macular edema with branch retinal vein occlusion. Int Ophthalmol 33(3):227\u2013236","journal-title":"Int Ophthalmol"},{"key":"89_CR16","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1159\/000223943","volume":"44","author":"DT Goldenberg","year":"2019","unstructured":"Goldenberg DT, Trese MT (2019) Pharmacologic vitreodynamics and molecular flux. Dev Ophthalmol 44:31\u201336","journal-title":"Dev Ophthalmol"},{"issue":"1","key":"89_CR17","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1586\/eop.09.70","volume":"5","author":"SS Shah","year":"2010","unstructured":"Shah SS, Denham LV, Elison JR, Bhattacharjee PS, Clement C, Huq T, Hill JM (2010) Drug delivery to the posterior segment of the eye for pharmacologic therapy. Expert Rev Ophthalmol 5(1):75\u201393","journal-title":"Expert Rev Ophthalmol"},{"issue":"6","key":"89_CR18","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1001\/archopht.1984.01040030677017","volume":"102","author":"A Yoshida","year":"1984","unstructured":"Yoshida A, Furukawa H, Delori FC, Bursell SE, Trempe CL, McMeel JW (1984) Effect of vitreous detachment on vitreous fluorophotometry. Arch Ophthalmol 102(6):857\u2013860","journal-title":"Arch Ophthalmol"},{"issue":"6","key":"89_CR19","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.preteyeres.2010.04.003","volume":"29","author":"A Laude","year":"2010","unstructured":"Laude A, Tan LE, Wilson CG, Lascaratos G, Elashry M, Aslam T, Patton N, Dhillon B (2010) Intravitreal therapy for neovascular age-related macular degeneration and inter-individual variations in vitreous pharmacokinetics. Prog Retin Eye Res 29(6):466\u2013475","journal-title":"Prog Retin Eye Res"},{"issue":"4","key":"89_CR20","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1001\/archopht.1982.01030030596009","volume":"100","author":"TC Prager","year":"1982","unstructured":"Prager TC, Chu HH, Garcia CA, Anderson RE (1982) The influence of vitreous change on vitreous fluorophotometry. Arch Ophthalmol 100(4):594\u2013596","journal-title":"Arch Ophthalmol"},{"issue":"2","key":"89_CR21","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1097\/IAE.0b013e3181e586b2","volume":"31","author":"DT Goldenberg","year":"2011","unstructured":"Goldenberg DT, Giblin FJ, Cheng M, Chintala SK, Trese MT, Drenser KA, Ruby AJ (2011) Posterior vitreous detachment with microplasmin alters the retinal penetration of intravitreal bevacizumab (Avastin) in rabbit eyes. Retina 31(2):393\u2013400","journal-title":"Retina"},{"issue":"3","key":"89_CR22","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1080\/09273940802687838","volume":"17","author":"PS Silva","year":"2009","unstructured":"Silva PS, Singh RJ, Bakri SJ, Lising RS, Santiago DE, Uy HS (2009) Vitreous concentration of triamcinolone acetonide after a single transseptal depot injection. Ocul Immunol Inflamm 17(3):216\u2013220","journal-title":"Ocul Immunol Inflamm"},{"issue":"7","key":"89_CR23","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1007\/s00417-013-2266-y","volume":"251","author":"U Geck","year":"2013","unstructured":"Geck U, Pustolla N, Baraki H, Atili A, Feltgen N, Hoerauf H (2013) Posterior vitreous detachment following intravitreal drug injection. Graefes Arch Clin Exp Ophthalmol 251(7):1691\u20131695","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"22","key":"89_CR24","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1056\/NEJM199412013312203","volume":"331","author":"LP Aiello","year":"1994","unstructured":"Aiello LP, Avery RL, Arrigg PG, Keyt BA, Jampel HD, Shah ST, Pasquale LR, Thieme H, Iwamoto MA, Park JE, Nguyen HV, Aiello LM, Ferrara N, King GL (1994) Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med 331(22):1480\u20131487","journal-title":"N Engl J Med"},{"issue":"10","key":"89_CR25","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1016\/j.ophtha.2004.03.035","volume":"111","author":"H Itakura","year":"2004","unstructured":"Itakura H, Kishi S, Kotajima N, Murakami M (2004) Persistent secretion of vascular endothelial growth factor into the vitreous cavity in proliferative diabetic retinopathy after vitrectomy. Ophthalmology 111(10):1880\u20131884","journal-title":"Ophthalmology"},{"issue":"6","key":"89_CR26","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1177\/112067210801800628","volume":"18","author":"H Noma","year":"2008","unstructured":"Noma H, Funatsu H, Mimura T, Hori S (2008) Changes of vascular endothelial growth factor after vitrectomy for macular edema secondary to retinal vein occlusion. Eur J Ophthalmol 18(6):1017\u20131019","journal-title":"Eur J Ophthalmol"},{"issue":"1","key":"89_CR27","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.ajo.2012.01.010","volume":"154","author":"K Yamashiro","year":"2012","unstructured":"Yamashiro K, Tomita K, Tsujikawa A, Nakata I, Akagi-Kurashige Y, Miyake M, Ooto S, Tamura H, Yoshimura N (2012) Factors associated with the response of age-related macular degeneration to intravitreal ranibizumab treatment. Am J Ophthalmol 154(1):125\u2013136","journal-title":"Am J Ophthalmol"},{"issue":"4","key":"89_CR28","first-page":"261","volume":"9","author":"Aflibercept","year":"2008","unstructured":"Aflibercept (2008) AVE 0005, AVE 005, AVE0005, VEGF Trap\u2014Regeneron, VEGF Trap (R1R2). VEGF Trap-Eye. Drugs RD 9(4):261\u2013269","journal-title":"VEGF Trap-Eye. Drugs RD"},{"issue":"2","key":"89_CR29","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s40123-013-0015-2","volume":"2","author":"K Trichonas","year":"2013","unstructured":"Trichonas K, Kaiser PK (2013) Aflibercept for the treatment of age-related macular degeneration. Ophthalmol Ther 2(2):89\u201398","journal-title":"Ophthalmol Ther"}],"container-title":["International Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-015-0089-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10792-015-0089-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-015-0089-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,26]],"date-time":"2019-08-26T03:40:25Z","timestamp":1566790825000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10792-015-0089-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6,5]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,4]]}},"alternative-id":["89"],"URL":"https:\/\/doi.org\/10.1007\/s10792-015-0089-z","relation":{},"ISSN":["0165-5701","1573-2630"],"issn-type":[{"value":"0165-5701","type":"print"},{"value":"1573-2630","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,6,5]]}}}